Navigation Links
Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
Date:5/21/2012

STEWARTVILLE, Minn., May 21, 2012 /PRNewswire/ -- Rochester Medical Corporation (NASDAQ: ROCM) is pleased to announce an addition to its Magic3 Intermittent Catheter line with the launch of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip and Insertion Sleeve. 

This new catheter is the very latest Magic3 technology. It provides the added benefits of the touch-free gripping device, combined with a specially designed curved tip configuration.

The Coude tip is designed to aid insertion, especially around natural curves within the urethra. Coude tip catheters are often used by men with an enlarged prostate, narrowing of the urethra, or bladder neck contractures. Magic3 intermittent catheters leverage Rochester Medical's proprietary m3 technology to deliver the benefits of a three-layer all-silicone design. They are the first Coude intermittent catheters created and crafted from a composition of three distinct functional layers.  Each uniquely formulated layer independently addresses a particular product attribute required for comfortable, easy, and reliable intermittent catheterization. 

In this new offering, Rochester Medical has incorporated additional important design enhancements. The patent-pending insertion sleeve provides touch-free insertion while allowing the user to firmly grip the catheter surface, making it easier to maneuver. The insertion sleeve is sterilized and located inside the packaging. This new feature is designed to provide the user more control while minimizing risk of contamination while catheterizing. 

Kicking-off a comprehensive sales campaign, Rochester Medical has begun rolling out the new Magic3 Coude in the U.S. via introductions to its distribution partners and targeted clinical call points. 

The Magic3 catheters are available in male (16") length and in diameters ranging from 10Fr to 18Fr.  Most state Medicaid, Medicare, and private insurance companies will cover these advanced catheters; local product suppliers can provide details about specific payor sources. Additional product and ordering information is available by contacting Rochester Medical at 1-800-243-3315 or info@rocm.com.

For over two decades, Rochester Medical Corporation has been developing, manufacturing, and marketing latex-free and PVC-free disposable medical devices for urological and continence care applications. Manufactured in the USA with an environmentally conscious design, the all-silicone Magic3 Intermittent Catheter with Coude Tip and Insertion Sleeve is yet another example of the Company's commitment to providing innovative solutions to address the needs of patients, caregivers, and clinicians.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500.  More information about Rochester Medical is available on its website at http://www.rocm.com.


'/>"/>
SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
2. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
3. Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009
4. Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
5. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
6. Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
7. AstraZeneca Joins Rochester Initiative to Further Cardiac Safety
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. Rochester Medical Reports Fourth Quarter and Year-End Results
10. Rochester Medical Corporation Announces Agreement to Acquire Laprolan B.V.
11. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/27/2016)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... second quarter ended March 26, 2016.  GAAP diluted ... and non-GAAP diluted EPS of $0.47 increased 14.6%.  ... reported basis, and 6.3% on a constant currency ... quarter, highlighted by 14.6% growth in non-GAAP EPS," ...
(Date:4/27/2016)... York , April 27, 2016 ... report titled, "Skincare Devices Market - Global Industry Analysis, ... According to the report, the global skincare devices market ... is anticipated to expand at a CAGR of 10.1% ... in 2023. Browse the full Skincare Devices Market ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Coast Dental Fort Stewart ... at its new location in the Exchange Furniture Mall at 112 Vilseck Road in ... 50-inch Samsung Smart TV. Plus attendees will have the opportunity to meet general dentists ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton ... $30,000 Perlman Grand Prize of the 2016 Wharton Business Plan Competition —as ... People’s Choice Award, and the Committee Award for Most ‘Wow Factor,’ making them ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program ... to announce the launch of the GFCP Scoop in response to ... purpose of the GFCP Scoop site is to keep the gluten-free ...
(Date:4/29/2016)... ... April 29, 2016 , ... New York City based oral and maxillofacial surgeon Dr. ... very effective way to treat obstructive sleep apnea. Dr. Jamali is proud to offer this ... procedure that involves one or both jaw bones. This surgery is performed to correct the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the ... of funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... base and accelerate its technology and product roadmap. , “Jvion is ...
Breaking Medicine News(10 mins):